The majority of Croatian hematologists (93.5%) also test for CALR and MPL mutations if JAK2-V617F mutation is negative in cases of ET and MF suspicion; 73.5% of them also perform bone marrow biopsy when ET is suspected. Here, JAK2 is linked to essential thrombocythemia.